Mayersohn Joel David 4
4 · CITIUS ONCOLOGY, INC. · Filed Sep 23, 2025
Insider Transaction Report
Form 4
Mayersohn Joel David
Director
Transactions
- Award
Common Stock
2025-09-19+300,000→ 321,228 total
Holdings
- 250,000
Stock Option (Right to Buy)
Exercise: $1.07Exp: 2034-12-12→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- [F2]These options were granted on December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.